Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35 (2013), Issue 5, Pages 395–405
http://dx.doi.org/10.1155/2013/983981
Research Article

Increased LEF1 Expression and Decreased Notch2 Expression Are Strong Predictors of Poor Outcomes in Colorectal Cancer Patients

Department of Oncology, First Affiliated Hospital of Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

Received 23 April 2013; Revised 14 July 2013; Accepted 5 August 2013

Academic Editor: Ahmed O. Kaseb

Copyright © 2013 Wen-Juan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Gansler, P. A. Ganz, M. Grant et al., “Sixty years of ca: a cancer journal for clinicians,” CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Lei, W.-Q. Chen, S.-W. Zhang et al., “Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002,” Zhonghua Zhong Liu Za Zhi, vol. 31, no. 6, pp. 428–433, 2009. View at Google Scholar · View at Scopus
  4. P. Andreu, S. Colnot, C. Godard et al., “Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine,” Development, vol. 132, no. 6, pp. 1443–1451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Fre, M. Huyghe, P. Mourikis, S. Robine, D. Louvard, and S. Artavanis-Tsakonas, “Notch signals control the fate of immature progenitor cells in the intestine,” Nature, vol. 435, no. 7044, pp. 964–968, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Fre, S. K. Pallavi, M. Huyghe et al., “Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 15, pp. 6309–6314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. van Es, M. E. van Gijn, O. Riccio et al., “Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells,” Nature, vol. 435, no. 7044, pp. 959–963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Van Es and H. Clevers, “Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease,” Trends in Molecular Medicine, vol. 11, no. 11, pp. 496–502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Shitashige, S. Hirohashi, and T. Yamada, “Wnt signaling inside the nucleus,” Cancer Science, vol. 99, no. 4, pp. 631–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-W. Li, J.-H. Ting, N. N. Yokoyama, A. Bernstein, M. Van De Wetering, and M. L. Waterman, “Wnt activation and alternative promoter repression of LEF1 in colon cancer,” Molecular and Cellular Biology, vol. 26, no. 14, pp. 5284–5299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. N. Shelton, H. Fornalik, T. Neff et al., “The role of LEF1 in endometrial gland formation and carcinogenesis,” Plos One, vol. 7, Article ID e40312, 2012. View at Google Scholar
  12. L. E. Valdivia, R. M. Young, T. A. Hawkins et al., “Lef1-dependent Wnt/β-catenin signalling drives the proliferative engine that maintains tissue homeostasis during lateral line development,” Development, vol. 138, no. 18, pp. 3931–3941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. H. Metzeler, B. Heilmeier, K. E. Edmaier et al., “High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia,” Blood, vol. 120, pp. 2118–2126, 2012. View at Google Scholar
  14. L. H. Hoeppner, F. J. Secreto, D. F. Razidlo, T. J. Whitney, and J. J. Westendorf, “Lef1ΔN binds β-catenin and increases osteoblast activity and trabecular bone mass,” Journal of Biological Chemistry, vol. 286, no. 13, pp. 10950–10959, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L.-K. Phng, M. Potente, J. D. Leslie et al., “Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis,” Developmental Cell, vol. 16, no. 1, pp. 70–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. K. Noah and N. F. Shroyer, “Notch in the intestine: regulation of homeostasis and pathogenesis,” Annual Review of Physiology, vol. 75, pp. 263–288, 2013. View at Google Scholar
  17. J.-L. Li, R. C. Sainson, C. E. Oon et al., “DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo,” Cancer Research, vol. 71, no. 18, pp. 6073–6083, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. G. P. Dotto, “Notch tumor suppressor function,” Oncogene, vol. 27, no. 38, pp. 5115–5123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Pannuti, K. Foreman, P. Rizzo et al., “Targeting Notch to target cancer stem cells,” Clinical Cancer Research, vol. 16, no. 12, pp. 3141–3152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Sasaki, H. Suzuki, K. Yagi et al., “Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor β-induced repression of c-myc,” Cancer Research, vol. 63, no. 4, pp. 801–806, 2003. View at Google Scholar · View at Scopus
  21. D. Chu, J. Zheng, W. Wang et al., “Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status,” Annals of Surgical Oncology, vol. 16, no. 12, pp. 3259–3266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Liu, S. Wang, X. Xia et al., “Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer,” Plos One, vol. 7, Article ID e52348, 2012. View at Google Scholar
  23. T. Tian, K.-J. Nan, S.-H. Wang et al., “PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells,” Carcinogenesis, vol. 31, no. 7, pp. 1211–1219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Barbareschi, P. Maisonneuve, D. Aldovini et al., “High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis,” Cancer, vol. 98, no. 3, pp. 474–483, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Liu, H. Zhang, L. Lai et al., “Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers,” Clinical Science, vol. 124, no. 9, pp. 567–578, 2013. View at Google Scholar
  26. W. Weichert, A. Röske, V. Gekeler et al., “Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis,” The Lancet Oncology, vol. 9, no. 2, pp. 139–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Kriegl, D. Horst, J. A. Reiche, J. Engel, T. Kirchner, and A. Jung, “LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer,” Journal of Translational Medicine, vol. 8, article 123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Chu, Z. Zhang, Y. Zhou et al., “Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer,” Annals of Oncology, vol. 22, no. 11, pp. 2440–2447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A.-Y. Lin, M.-S. Chua, Y.-L. Choi et al., “Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker,” PLoS One, vol. 6, no. 2, Article ID e16636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Giese, A. Amsterdam, and R. Grosschedl, “DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1,” Genes and Development, vol. 5, no. 12, pp. 2567–2578, 1991. View at Google Scholar · View at Scopus
  31. A. Milatovich, A. Travis, R. Grosschedl, and U. Francke, “Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf,” Genomics, vol. 11, no. 4, pp. 1040–1048, 1991. View at Google Scholar · View at Scopus
  32. K. Hovanes, T.-W. Li, J. E. Munguia et al., “β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer,” Nature Genetics, vol. 28, no. 1, pp. 53–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Reya and H. Clevers, “Wnt signalling in stem cells and cancer,” Nature, vol. 434, no. 7035, pp. 843–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. R. T. Moon, A. D. Kohn, G. V. De Ferrari, and A. Kaykas, “WNT and β-catenin signalling: diseases and therapies,” Nature Reviews Genetics, vol. 5, no. 9, pp. 691–701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Å. Apelqvist, H. Li, L. Sommer et al., “Notch signalling controls pancreatic cell differentiation,” Nature, vol. 400, no. 6747, pp. 877–881, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Miyamoto and D. W. Rosenberg, “Role of Notch signaling in colon homeostasis and carcinogenesis,” Cancer Science, vol. 102, no. 11, pp. 1938–1942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S.-Y. Lee, K. Kumano, K. Nakazaki et al., “Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma,” Cancer Science, vol. 100, no. 5, pp. 920–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. C. F. O'Neill, S. Urs, C. Cinelli et al., “Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth,” American Journal of Pathology, vol. 171, no. 3, pp. 1023–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Parr, G. Watkins, and W.-G. Jiang, “The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer,” International Journal of Molecular Medicine, vol. 14, no. 5, pp. 779–786, 2004. View at Google Scholar · View at Scopus
  40. J. Ungerbäck, N. Elander, J. Grünberg, M. Sigvardsson, and P. Söderkvist, “The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells,” PLoS One, vol. 6, no. 3, Article ID e17957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. F. E. Bertrand, C. W. Angus, W. J. Partis, and G. Sigounas, “Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch,” Cell Cycle, vol. 11, no. 23, pp. 4344–4351, 2012. View at Google Scholar
  42. C. Spaulding, E. J. Reschly, D. E. Zagort et al., “Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas,” Blood, vol. 110, no. 7, pp. 2650–2658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Fan, I. Mikolaenko, I. Elhassan et al., “Notch1 and Notch2 have opposite effects on embryonal brain tumor growth,” Cancer Research, vol. 64, no. 21, pp. 7787–7793, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-H. Wang, K.-J. Nan, Y.-C. Wang, W.-J. Wang, and T. Tian, “The balance between two isoforms of LEF-1 regulates colon carcinoma growth,” BMC Gastroenterol, vol. 12, article 53, 2012. View at Google Scholar